120 related articles for article (PubMed ID: 37947329)
1. Approaches to developing de novo cancer population models to examine questions about cancer and race in bladder, gastric, and endometrial cancer and multiple myeloma: the Cancer Intervention and Surveillance Modeling Network incubator program.
Sereda Y; Alarid-Escudero F; Bickell NA; Chang SH; Colditz GA; Hur C; Jalal H; Myers ER; Layne TM; Wang SY; Yeh JM; Trikalinos TA;
J Natl Cancer Inst Monogr; 2023 Nov; 2023(62):219-230. PubMed ID: 37947329
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Uterine cancer in breast cancer survivors: a systematic review.
Wijayabahu AT; Egan KM; Yaghjyan L
Breast Cancer Res Treat; 2020 Feb; 180(1):1-19. PubMed ID: 31897901
[TBL] [Abstract][Full Text] [Related]
4. Trends in endometrial cancer incidence rates in the United States, 1999-2006.
Duong LM; Wilson RJ; Ajani UA; Singh SD; Eheman CR
J Womens Health (Larchmt); 2011 Aug; 20(8):1157-63. PubMed ID: 21682550
[TBL] [Abstract][Full Text] [Related]
5. Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA.
Schafer EJ; Jemal A; Wiese D; Sung H; Kratzer TB; Islami F; Dahut WL; Knudsen KE
Eur Urol; 2023 Jul; 84(1):117-126. PubMed ID: 36566154
[TBL] [Abstract][Full Text] [Related]
6. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
[TBL] [Abstract][Full Text] [Related]
7. Biological determinants of health disparities in multiple myeloma.
Smith CJ; Ambs S; Landgren O
Blood Cancer J; 2018 Aug; 8(9):85. PubMed ID: 30190459
[TBL] [Abstract][Full Text] [Related]
8. Population simulation modeling of disparities in US breast cancer mortality.
Mandelblatt JS; Schechter CB; Stout NK; Huang H; Stein S; Hunter Chapman C; Trentham-Dietz A; Jayasekera J; Gangnon RE; Hampton JM; Abraham L; O'Meara ES; Sheppard VB; Lee SJ
J Natl Cancer Inst Monogr; 2023 Nov; 2023(62):178-187. PubMed ID: 37947337
[TBL] [Abstract][Full Text] [Related]
9. Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis.
Doll KM; Winn AN
Am J Obstet Gynecol; 2019 Oct; 221(4):318.e1-318.e9. PubMed ID: 31125544
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of secondary solid tumor malignancies among patients with myeloma: A population-based study.
Barth P; Castillo JJ; Olszewski AJ
Cancer; 2019 Feb; 125(4):550-558. PubMed ID: 30452087
[TBL] [Abstract][Full Text] [Related]
11. Endometrial cancer disparities: a race-conscious critique of the literature.
Doll KM; Snyder CR; Ford CL
Am J Obstet Gynecol; 2018 May; 218(5):474-482.e2. PubMed ID: 28964822
[TBL] [Abstract][Full Text] [Related]
12. Role of bleeding recognition and evaluation in Black-White disparities in endometrial cancer.
Doll KM; Khor S; Odem-Davis K; He H; Wolff EM; Flum DR; Ramsey SD; Goff BA
Am J Obstet Gynecol; 2018 Dec; 219(6):593.e1-593.e14. PubMed ID: 30291839
[TBL] [Abstract][Full Text] [Related]
13. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008.
Jamison PM; Noone AM; Ries LA; Lee NC; Edwards BK
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):233-41. PubMed ID: 23239812
[TBL] [Abstract][Full Text] [Related]
14. Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial-ethnic group, United States 2003-2016.
Ellington TD; Henley SJ; Wilson RJ; Wu M; Richardson LC
Cancer Med; 2021 Jan; 10(1):386-395. PubMed ID: 33270992
[TBL] [Abstract][Full Text] [Related]
15. Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality.
Chang Y; Schechter CB; van Ravesteyn NT; Near AM; Heijnsdijk EA; Adams-Campbell L; Levy D; de Koning HJ; Mandelblatt JS
Breast Cancer Res Treat; 2012 Dec; 136(3):823-35. PubMed ID: 23104221
[TBL] [Abstract][Full Text] [Related]
16. Adapting a model of cervical carcinogenesis to self-identified Black women to evaluate racial disparities in the United States.
Spencer JC; Burger EA; Campos NG; Regan MC; Sy S; Kim JJ
J Natl Cancer Inst Monogr; 2023 Nov; 2023(62):188-195. PubMed ID: 37947333
[TBL] [Abstract][Full Text] [Related]
17. Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States.
Long B; Liu FW; Bristow RE
Gynecol Oncol; 2013 Sep; 130(3):652-9. PubMed ID: 23707671
[TBL] [Abstract][Full Text] [Related]
18. Cancer mortality surveillance--United States, 1990-2000.
Stewart SL; King JB; Thompson TD; Friedman C; Wingo PA
MMWR Surveill Summ; 2004 Jun; 53(3):1-108. PubMed ID: 15179359
[TBL] [Abstract][Full Text] [Related]
19. Where you live can impact your cancer risk: a look at multiple myeloma in New York City.
Kamath GR; Renteria AS; Jagannath S; Gallagher EJ; Parekh S; Bickell NA
Ann Epidemiol; 2020 Aug; 48():43-50.e4. PubMed ID: 32620423
[TBL] [Abstract][Full Text] [Related]
20. Uterine Cancer Incidence and Mortality - United States, 1999-2016.
Henley SJ; Miller JW; Dowling NF; Benard VB; Richardson LC
MMWR Morb Mortal Wkly Rep; 2018 Dec; 67(48):1333-1338. PubMed ID: 30521505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
